Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sarah E. Frew"'
Publikováno v:
Nature Biotechnology. 27:427-445
Despite a challenging business environment, entrepreneurial health biotech companies in South Africa are finding ways to succeed.
Publikováno v:
Nature Biotechnology. 26:627-644
Brazil boasts world-class biomedical science, but tension between the public and private sectors hinders progress in health biotech innovation.
Autor:
Stephen Sammut, Sara Al-Bader, Rahim Rezaie, Sarah E Frew, Peter Singer, Abdallah S. Daar, Joshua K. Ramjist, Alysha F Shore
Publikováno v:
Nature Biotechnology
Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. Supplementary information The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized us
Publikováno v:
Nature Biotechnology. 25:403-417
India's home-grown biotech companies must strike a balance between domestic and international markets.
Publikováno v:
Genetics. 148:71-83
pep5 mutants of Saccharomyces cerevisiae accumulate inactive precursors to the vacuolar hydrolases. In addition, they show a vestigial vacuole morphology and a sensitivity to growth on media containing excess divalent cations. This pleiotropic phenot
Publikováno v:
Health Research Policy and Systems, Vol 10, Iss 1, p 18 (2012)
Health Research Policy and Systems
Health Research Policy and Systems
Biopharmaceutical innovation has had a profound health and economic impact globally. Developed countries have traditionally been the source of most innovations as well as the destination for the resulting economic and health benefits. As a result, mo
Publikováno v:
Health affairs (Project Hope). 28(6)
Although neglected tropical diseases (NTDs) threaten the health of those living in the developing world, innovation directed toward addressing NTDs is comparatively meager. Health biotechnology firms in rapidly growing economies in the global South a
Publikováno v:
Health affairs (Project Hope). 27(4)
India and China have made major progress toward establishing research- and innovation-based health biotechnology sectors. Local health needs, including diseases that predominantly affect the poor, have driven much of this success. We argue that emerg
Publikováno v:
International Journal of Biotechnology. 8:91
Developing countries can benefit from conducting innovative research and development in science and technology prioritised to their own specific health and development needs. Here, the role of the domestic private sector in utilising its knowledge, e